Positron emission tomography/computed tomography and biomarkers for early treatment response evaluation in metastatic colon cancer.
about
Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancerPrognostic value of positron emission tomography/computed tomography for adjuvant chemotherapy of colon cancer.18F-FDG PET/CT response in a phase 1/2 trial of nab-paclitaxel plus gemcitabine for advanced pancreatic cancer
P2860
Positron emission tomography/computed tomography and biomarkers for early treatment response evaluation in metastatic colon cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Positron emission tomography/c ...... on in metastatic colon cancer.
@en
Positron emission tomography/c ...... on in metastatic colon cancer.
@nl
type
label
Positron emission tomography/c ...... on in metastatic colon cancer.
@en
Positron emission tomography/c ...... on in metastatic colon cancer.
@nl
prefLabel
Positron emission tomography/c ...... on in metastatic colon cancer.
@en
Positron emission tomography/c ...... on in metastatic colon cancer.
@nl
P2093
P2860
P50
P1433
P1476
Positron emission tomography/c ...... on in metastatic colon cancer.
@en
P2093
Annika Loft
Bodil E Engelmann
Carsten Sloth
Elena Markova
Eric V Benzon
Ib J Christensen
Johan Löfgren
Michael H Kristensen
Niels H Holländer
Nils Brünner
P2860
P304
P356
10.1634/THEONCOLOGIST.2013-0229
P577
2014-01-22T00:00:00Z